Development of Diclofenac Potassium Sustained-Release Tablets and Exploration of Released Character

Zong Li,WANG Bo,ZHANG Ning
DOI: https://doi.org/10.3321/j.issn:1000-5048.2001.03.012
2001-01-01
Abstract:AIM Diclofenac potassium sustained-release tablets were developed as a gel matrix for using twice daily and evaluated in vitro release characteristics. METHODS The formulations were screened according to the designed in vitro release rate by the use of HPMC as the gel matrix and the hydrophobic retarding agent to modify the release. RESULTS The release was properly characterized by the diffusion mechanism, influenced by pH of the media, slightly affected by the basket rotating speed, without the influences from the pressure exerted during the tabletting procedure. CONCLUSION The selected formulation of diclofenac potassium sustained-release tablets could ensure the desired in vitro release rate. In addition, it proved a good manufacturing reproducibility.
What problem does this paper attempt to address?